会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Medical treatment using an ultrasound phased array
    • 使用超声相控阵的医疗
    • US08287471B2
    • 2012-10-16
    • US12033370
    • 2008-02-19
    • Hao-li LiuWin-li LinHsu Chang
    • Hao-li LiuWin-li LinHsu Chang
    • A61N7/02
    • A61N7/02A61B34/10A61B90/37A61B2090/392
    • A medical system and method for treating a disorder of a subject by thermal ablation, e.g., focused ultrasound thermal ablation, are provided. The method includes obtaining medical images that include at least one image of subject's chest and ribs to reconstruct a three-dimensional chest-rib distribution; and applying ultrasound waves on a target point beyond the subject's ribs by selectively activating one or more elements of an ultrasound phased array to avoid ultrasonic energy absorption or reflection by an intervening rib based on a calculation of a relationship between the three-dimensional chest-rib distribution and an acoustic emission direction.
    • 提供了一种通过热消融治疗受试者病症的医疗系统和方法,例如聚焦超声热消融。 该方法包括获得包括受试者胸部和肋骨的至少一个图像的医学图像,以重建三维胸肋分布; 以及通过选择性地激活超声相控阵列的一个或多个元件,将目标点上的超声波施加到目标点之上,以避免超声能量吸收或由中间肋反射,基于三维胸肋之间的关系的计算 分布和声发射方向。
    • 10. 发明申请
    • TREATMENT OF BRAIN DISEASES VIA ULTRASOUND/MAGNETIC TARGETING DELIVERY AND TRACING OF THERAPEUTIC AGENTS
    • 通过超声波/磁性定向递送和治疗药物的治疗来治疗脑疾病
    • US20120095325A1
    • 2012-04-19
    • US13273368
    • 2011-10-14
    • Kuo-Chen WeiHao-Li LiuMu-Yi Hua
    • Kuo-Chen WeiHao-Li LiuMu-Yi Hua
    • A61B5/055A61N7/00B82Y5/00
    • A61B5/0515A61B5/0042A61M37/0092A61M2210/0693B82Y5/00
    • Disclosed herein is a method for treating a brain disease in which focused ultrasound and magnetic targeting are applied to a subject in need of such treatment, so that therapeutic agent-magnetic nanoparticle composites are directed across the blood-brain barrier to a designated locus inside the brain of the subject. Each of the composites includes a magnetic nanoparticle that is formed of an iron-based core and a shell encapsulating the iron-based core, and a therapeutic agent that is bound to the shell of the magnetic nanoparticle. The magnetic nanoparticle has a size ranging from 5 to 200 nm. The iron-based core has a crystalline structure that imparts the composites with a sufficiently high magnetization, thereby enhancing magnetic targeting of the composites to the designated locus inside the brain of the subject. The magnetic targeting treatment is conducted via a magnet providing a magnetic flux density not less than 0.18 T.
    • 本文公开了一种治疗脑疾病的方法,其中将聚焦超声和磁性靶向应用于需要这种治疗的受试者,使得治疗剂 - 磁性纳米颗粒复合物穿过血脑屏障被引导到内部的指定位点 主题的大脑。 每种复合材料包括由铁基核心和包封铁基核心的壳形成的磁性纳米颗粒,以及结合到磁性纳米颗粒的壳的治疗剂。 磁性纳米粒子的尺寸范围为5〜200nm。 铁基芯具有赋予复合材料足够高的磁化强度的晶体结构,从而增强复合材料对受试者脑内指定位点的磁性靶向。 磁性靶向处理通过提供磁通密度不小于0.18T的磁体进行。